Atlas Trials

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Clinical trial NCT00052416 · COMPLETED

Trial details

NCT number
NCT00052416
Sponsor
Beth Israel Deaconess Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaLymphoma
Start date
2002-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.